[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL369552A1 - Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions - Google Patents

Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions

Info

Publication number
PL369552A1
PL369552A1 PL369552A PL36955204A PL369552A1 PL 369552 A1 PL369552 A1 PL 369552A1 PL 369552 A PL369552 A PL 369552A PL 36955204 A PL36955204 A PL 36955204A PL 369552 A1 PL369552 A1 PL 369552A1
Authority
PL
Poland
Prior art keywords
nutrient
pharmaceutical
laboratory preparation
functioning
functions
Prior art date
Application number
PL369552A
Other languages
Polish (pl)
Inventor
Martyna Kandefer-Szerszeń
Wojciech Rzeski
Barbara Zdzisińska
Stefan Pierzynowski
Original Assignee
Sgp & Sons Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sgp & Sons Ab filed Critical Sgp & Sons Ab
Priority to PL369552A priority Critical patent/PL369552A1/en
Priority to PCT/PL2005/000051 priority patent/WO2006016828A2/en
Publication of PL369552A1 publication Critical patent/PL369552A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL369552A 2004-08-12 2004-08-12 Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions PL369552A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL369552A PL369552A1 (en) 2004-08-12 2004-08-12 Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions
PCT/PL2005/000051 WO2006016828A2 (en) 2004-08-12 2005-08-11 Use of alpha ketoglutarate for treating alzheimer, parkinson

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL369552A PL369552A1 (en) 2004-08-12 2004-08-12 Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions

Publications (1)

Publication Number Publication Date
PL369552A1 true PL369552A1 (en) 2006-02-20

Family

ID=35462217

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369552A PL369552A1 (en) 2004-08-12 2004-08-12 Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions

Country Status (2)

Country Link
PL (1) PL369552A1 (en)
WO (1) WO2006016828A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2665466T3 (en) 2010-02-18 2018-04-25 Osiris Therapeutics, Inc. Applications related to immunocompatible chorionic membrane products
DK2897604T3 (en) * 2012-09-19 2018-08-06 Grespo Ab COMPOSITIONS FOR IMPROVING BRAIN FUNCTION
US20150328176A1 (en) * 2013-01-25 2015-11-19 Winning The Fight Inc. Composition for treatment of neurodegenerative disease
WO2019038655A1 (en) * 2017-08-21 2019-02-28 The Regents Of The University Of California Compositions and methods for treating neurodegenerative diseases
CN117530940A (en) * 2023-10-11 2024-02-09 四川大学华西第二医院 Application of alpha-ketoglutarate in preparation of medicines for promoting myelin repair and improving neuroinflammation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402027D0 (en) * 1994-06-10 1994-06-10 Pharmacia Ab Energy substrates
WO1999021565A1 (en) * 1997-10-24 1999-05-06 Cornell Research Foundation, Inc. Nutritional supplement for cerebral metabolic insufficiencies
DE19755367C2 (en) * 1997-12-12 2001-03-22 Afting Ernst Guenter Pharmaceutical composition containing D-galactose and its use
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
US20020193335A1 (en) * 2001-03-02 2002-12-19 Hesson David P. Gene therapy for neurological tissues
FR2822704B1 (en) * 2001-03-29 2005-02-18 Chiesi Sa SALTS OF KETOACIDES AND GASTRORESISTANT AMINO ACIDS AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS
NZ530554A (en) * 2004-01-13 2004-04-30 A Neuronutrients

Also Published As

Publication number Publication date
WO2006016828A8 (en) 2007-07-19
WO2006016828A2 (en) 2006-02-16
WO2006016828A3 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
WO2008080134A3 (en) 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
CL2007002017A1 (en) COMPOUNDS DERIVED FROM [4,5 '] - BIPIRIMIDINIL-6,4'-DIAMINE; PHARMACEUTICAL COMPOSITION; AND USE AS AN INHIBITOR OF THE ACTIVITY OF CINASA IN CANCER DE VEJIGA, CANCER CERVICAL AND MIELOMA MULTIPLE.
EP2476679A3 (en) Substituted triazoles useful as AXL inhibitors
TWI320316B (en) Methods for inhibiting hscd activity,pyridazine derivatives and use and pharmaceutical composition thereof
EP1844022A4 (en) Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof
IL182876A0 (en) Lactam compounds and their use as pharmaceuticals
WO2007022245A3 (en) Patient compliance system and method to promote patient compliance
ZA200610576B (en) Ablation apparatus and system to limit nerve condition
IL192009A0 (en) Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
EP1963500A4 (en) Compositions comprising oriented, immobilized macromolecules and methods for their preparation
ZA201000314B (en) 2, 3-dihydrobenzo[1, 4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
HK1207883A1 (en) Cell culture method and utilization of the same
IL190219A0 (en) Compounds which have activity at m1 receptor and their uses in medicine
IL179253A0 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
IL190231A0 (en) Phenyl-and pyridinyl-1,2,4-oxadiazolone derivatives processes for their preparation and their use as pharmaceuticals
HK1112916A1 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof 3-
ME01400B (en) Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
ZA200700397B (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
EP2035406A4 (en) Novel substituted-1h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same
PL369552A1 (en) Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions
WO2006133194A3 (en) Methods for treating viral infection with oral or injectible drug solution
HK1124780A1 (en) Amidine derivatives and their uses as medicine

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)